OKYO PHARMA LTD (OKYO) Fundamental Analysis & Valuation

NASDAQ:OKYO • GG00BMFG5F62

Current stock price

1.51 USD
-0.07 (-4.43%)
Last:

This OKYO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. OKYO Profitability Analysis

1.1 Basic Checks

  • OKYO had negative earnings in the past year.
  • OKYO had a negative operating cash flow in the past year.
  • In the past 5 years OKYO always reported negative net income.
  • In the past 5 years OKYO always reported negative operating cash flow.
OKYO Yearly Net Income VS EBIT VS OCF VS FCFOKYO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 -5M -10M -15M -20M

1.2 Ratios

  • OKYO has a worse Return On Assets (-99.35%) than 75.53% of its industry peers.
Industry RankSector Rank
ROA -99.35%
ROE N/A
ROIC N/A
ROA(3y)-491.55%
ROA(5y)-329.24%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OKYO Yearly ROA, ROE, ROICOKYO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K -6K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for OKYO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OKYO Yearly Profit, Operating, Gross MarginsOKYO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. OKYO Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for OKYO has been increased compared to 1 year ago.
  • Compared to 5 years ago, OKYO has more shares outstanding
  • There is no outstanding debt for OKYO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
OKYO Yearly Shares OutstandingOKYO Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
OKYO Yearly Total Debt VS Total AssetsOKYO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M 5M

2.2 Solvency

  • OKYO has an Altman-Z score of -46.47. This is a bad value and indicates that OKYO is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of OKYO (-46.47) is worse than 90.94% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -46.47
ROIC/WACCN/A
WACCN/A
OKYO Yearly LT Debt VS Equity VS FCFOKYO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M -4M -6M -8M

2.3 Liquidity

  • OKYO has a Current Ratio of 0.58. This is a bad value and indicates that OKYO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • OKYO's Current ratio of 0.58 is on the low side compared to the rest of the industry. OKYO is outperformed by 89.21% of its industry peers.
  • OKYO has a Quick Ratio of 0.58. This is a bad value and indicates that OKYO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • OKYO's Quick ratio of 0.58 is on the low side compared to the rest of the industry. OKYO is outperformed by 88.82% of its industry peers.
Industry RankSector Rank
Current Ratio 0.58
Quick Ratio 0.58
OKYO Yearly Current Assets VS Current LiabilitesOKYO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. OKYO Growth Analysis

3.1 Past

  • OKYO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 69.90%, which is quite impressive.
EPS 1Y (TTM)69.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.41%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • OKYO is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.21% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-26.47%
EPS Next 2Y-41.42%
EPS Next 3Y-23.47%
EPS Next 5Y-4.21%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OKYO Yearly Revenue VS EstimatesOKYO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2029 2030 2031 2032 2033 100M 200M 300M 400M
OKYO Yearly EPS VS EstimatesOKYO Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 0.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. OKYO Valuation Analysis

4.1 Price/Earnings Ratio

  • OKYO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OKYO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OKYO Price Earnings VS Forward Price EarningsOKYO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OKYO Per share dataOKYO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0.1 -0.2 -0.3 -0.4

4.3 Compensation for Growth

  • OKYO's earnings are expected to decrease with -23.47% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.42%
EPS Next 3Y-23.47%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. OKYO Dividend Analysis

5.1 Amount

  • OKYO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

OKYO Fundamentals: All Metrics, Ratios and Statistics

OKYO PHARMA LTD

NASDAQ:OKYO (3/27/2026, 2:17:08 PM)

1.51

-0.07 (-4.43%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)12-22
Earnings (Next)N/A
Inst Owners9.2%
Inst Owner Change-74.12%
Ins Owners31.06%
Ins Owner Change0%
Market Cap32.87M
Revenue(TTM)N/A
Net Income(TTM)-4.61M
Analysts82
Price Target8.16 (440.4%)
Short Float %2.9%
Short Ratio1.42
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4%
PT rev (3m)-20%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.78%
EPS NY rev (3m)-13.16%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.26
EYN/A
EPS(NY)-0.46
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.19
OCFYN/A
SpS0
BVpS-0.21
TBVpS-0.21
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -99.35%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-491.55%
ROA(5y)-329.24%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.58
Quick Ratio 0.58
Altman-Z -46.47
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)67.14%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)69.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.41%
EPS Next Y-26.47%
EPS Next 2Y-41.42%
EPS Next 3Y-23.47%
EPS Next 5Y-4.21%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y48.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y73.28%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y73.27%
OCF growth 3YN/A
OCF growth 5YN/A

OKYO PHARMA LTD / OKYO Fundamental Analysis FAQ

What is the ChartMill fundamental rating of OKYO PHARMA LTD (OKYO) stock?

ChartMill assigns a fundamental rating of 0 / 10 to OKYO.


What is the valuation status for OKYO stock?

ChartMill assigns a valuation rating of 0 / 10 to OKYO PHARMA LTD (OKYO). This can be considered as Overvalued.


Can you provide the profitability details for OKYO PHARMA LTD?

OKYO PHARMA LTD (OKYO) has a profitability rating of 0 / 10.


How financially healthy is OKYO PHARMA LTD?

The financial health rating of OKYO PHARMA LTD (OKYO) is 0 / 10.